Stocktoria
BELITE BIO, INC BLTE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2022-04-29
BELITE BIO, INC statistics & valuation
Market cap$6.0B
P / B7.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -9.9% | -23.8% | -33.4% | -28.6% | -52.7% |
| Return on equity | -10.1% | -24.8% | -35.0% | -30.5% | 64.0% |
| Current ratio | 50.02 | 24.31 | 24.76 | 20.35 | 10.66 |
Source: SEC EDGAR filings · CIK 0001889109 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.